WeightWatchers jumps into the prescription weight loss drug business | CNN Business

日本 ニュース ニュース

WeightWatchers jumps into the prescription weight loss drug business | CNN Business
日本 最新ニュース,日本 見出し
  • 📰 CNN
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 95%

WeightWatchers is getting into the booming prescription weight loss drug business.

The company, now known as WW International, will buy Sequence, a telehealth subscription service that connects patients with doctors who can prescribe weight-loss and diabetes drugs, including the hot new diabetes drug Ozempic. WeightWatchers offers subscribers meal plans and other tools to lose weight. Oprah Winfrey has a partnership with and stake in the company.

Shares of WW International \n \n surged 20% during pre-market trading Tuesday on the news. Although WeightWatchers didn’t specifically mention Ozempic or any other drug, the company noted that Sequence’s $99-a-month subscription plan helps connect customers to doctors who can prescribe drugs that mimic an appetite-regulating hormone called GLP-1. The GLP-1 agonists Sequence helps prescribe include Wegovy, Ozempic, and Rybelsus.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

CNN /  🏆 4. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

WeightWatchers gets into prescription weight loss businessWeightWatchers gets into prescription weight loss businessWith the acquisition of Sequence, the company is tapping into a red-hot market for prescription drugs that address obesity, and broadening what it offers to customers.
続きを読む »

CNN anchor Kasie Hunt gives birth in surprise 13-minute labor | CNN BusinessCNN anchor Kasie Hunt gives birth in surprise 13-minute labor | CNN BusinessCNN anchor and chief national affairs analyst Kasie Hunt and husband Matthew Mario Rivera welcomed their second child to the world last week in an unforgettable way.
続きを読む »

Head of UK business lobby steps aside following complaints about his conduct | CNN BusinessHead of UK business lobby steps aside following complaints about his conduct | CNN BusinessThe head of the main business lobby in the United Kingdom is stepping aside while an investigation takes place into complaints about his workplace conduct.
続きを読む »

WSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealWSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
続きを読む »

WeightWatchers Bets on So-Called Miracle Obesity Drug Ozempic in New Deal: ReportWeightWatchers Bets on So-Called Miracle Obesity Drug Ozempic in New Deal: ReportThe Wall Street Journal reported Monday that WeightWatchers is buying a telehealth subscription service called Sequence, which allows doctors to prescribe both Ozempic and its sister drug, Wegovy.
続きを読む »

WeightWatchers Buying Telehealth Service Known For Ozempic Weight Loss Prescriptions, Report SaysWeightWatchers Buying Telehealth Service Known For Ozempic Weight Loss Prescriptions, Report SaysWW’s stock jumped more than 13% in after-hours trading following news of the deal Monday.
続きを読む »



Render Time: 2025-03-04 12:24:10